Profil
Kevin Michael Baum served as a Director at Acuvax Ltd.
and as an Independent Non-Executive Director at Plus Connect Ltd.
from 2014 to 2016.
Anciens postes connus de Kevin Michael Baum
| Sociétés | Poste | Fin |
|---|---|---|
| PLUS CONNECT LTD | Director/Board Member | 01/06/2016 |
Acuvax Ltd.
 Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Health Technology |
Plus Connect Ltd.
 Plus Connect Ltd. Packaged SoftwareTechnology Services Plus Connect Ltd. operates as an information technology company, which develops charitable donations app. It also offers a micro-payments platform allowing users to make regular donations to charities and other fund raising organizations via their mobile phone. The company was founded on May 6, 2009 and is headquartered in Melbourne, Australia. | Technology Services |
